Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × Observation × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 7 Neoplasms 4 Lung Neoplasms 4 Breast Neoplasms 4 Prostatic Neoplasms 3 Oropharyngeal Neoplasms 3 Stomach Neoplasms 2 Neoplasm Metastasis 2 Mouth Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myeloid, Acute 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Trauma, Nervous System 1 Thoracic Injuries 1 Surgical Wound Dehiscence 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Retinoblastoma 1 Rectal Neoplasms 1 Radiculopathy 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleuropulmonary blastoma 1 Pilonidal Sinus 1 Pathologic Complete Response 1

Interventions

Bevacizumab 24 atezolizumab 19 durvalumab 18 Specimen Handling 15 pembrolizumab 12 lenvatinib 11 Magnetic Resonance Spectroscopy 11 tremelimumab 10 Nivolumab 10 Sorafenib 8 Radiosurgery 8 Cyclophosphamide 6 camrelizumab 5 apatinib 5 Ipilimumab 5 tislelizumab 4 regorafenib 4 fludarabine 4 cabozantinib 4 X-Rays 4 Immunoglobulin G 4 sintilimab 3 gadolinium ethoxybenzyl DTPA 3 Immune Checkpoint Inhibitors 3 Ethiodized Oil 3 E-7386 3 Disulfides 3 Blood Specimen Collection 3 Biopsy 3 gadobutrol 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡